Court denies renovaro motion for an expedited trial in july

Pittsburgh, may 27, 2025 (globe newswire) -- predictive oncology inc. (nasdaq: poai), a leader in ai-driven drug discovery, today issued the following statement regarding its dispute with renovaro, inc.

POAI Ratings Summary

POAI Quant Ranking